Samuel C Dudley
Prof Samuel C Dudley, MD, PhD, FACP, FACC is an expert in Cardiology at University of Minnesota (United States). Samuel C Dudley has authored 294 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 1,531 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Genetics - Nutrition - Histology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Dr. Dudley is a physician scientist and Professor of Medicine at the Lillehei Heart Institute (LHI) of the University of Minnesota. He was a Chief of Cardiology in three Universities over 22 years and the former Director of the LHI. He is a Fellow of the American College of Cardiology and American Heart Association, Editorial Board member for the Journal of the American College of Cardiology, and a member of the Association of University Cardiologists and the American Society for Clinical Investigation. He is the founder of Diastol, a company commercializing treatments for heart failure with preserved ejection fraction. His research program focuses on inflammation and its effects on arrhythmia and diastolic heart failure. He has submitted more than 30 patent applications on new diagnostics and therapeutics in these areas.
Organizations
Career arc: 1990 - 2026University of Minnesota
2018 - 2026
Heart Institute
2022 - 2026
Number : 294
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| NIMA-Related Kinase-7 Activates Atrial Cardiomyocyte NLRP3 Inflammasome and Associates With Occurrence of Postoperative Atrial Fibrillation. PMID 42841201 — hypertension, hyperlipidemias, coronary artery disease, arrhythmias, cardiac, inflammasomes, nima-related kinases, atrial fibrillation, myocytes, cardiac | Circ Arrhythm Electrophysiol | 2026 | 0 |
| Cardiac Sodium Channel Regulation: A Potential New Therapeutic Target in Cardiomyopathy. PMID 42024714 — heart failure, arrhythmias, cardiac, cardiovascular system, mitochondria, ion channels, therapeutics, sodium channels, cardiomyopathies | Circ Res | 2026 | 0 |
| Stress-Induced Down-Regulation of CPEB4 Disrupts Sodium Channel Regulation and Myocardial Excitability. PMID 41846068 — polyadenylation, heart failure, heart, arrhythmias, cardiac, stress, physiological, ion channels, down-regulation, sodium channels | JACC Basic Transl Sci | 2026 | 0 |
| Large-Scale Proteomic Profiling of Incident Heart Failure and Its Subtypes in Older Adults. PMID 41636061 — genes, myocardial infarction, heart failure, heart, cardiovascular diseases, heart failure, diastolic, heart failure, systolic, proteomics, therapeutics, random allocation, complement c9 | Circ Genom Precis Med | 2026 | 0 |
| Type 1 diabetes mellitus and atrial fibrillation - clinical relationships, mechanistic insights and therapeutic implications. PMID 41296793 — diabetes mellitus, atrial fibrillation, risk factors, therapeutics, diabetes mellitus, type 1 | Cardiovasc Res | 2025 | 0 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map